Skip to main content
SpringerLink
Log in

Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

There is controversy in the literature regarding the effects of endogenous hormones on estrogen receptors (ER) and progesterone receptors (PR) in young women with breast cancer.

We studied 117 young women with primary breast cancer and assessed their breast biopsies for ER and PR. The women had a record of their last menstrual period prior to breast biopsy. The menstrual cycle was divided into four phases — early proliferative (days 1–7), late proliferative (days 8–15), early secretory (days 16–22), and late secretory (days 23–30). There were lower levels of both ER and PR in biopsies excised during the early secretory phase than in other phases of the cycle; early proliferative phase receptor positive medians of ER = 77 fmol/mg protein and PR = 467 fmol/mg protein fell to ER = 28 fmol/mg and PR = 128 fmol/mg protein in the early secretory phase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Clark GM, McGuire WL: Prognostic factors in primary breast cancer. Breast Cancer Res Treat 3 (Suppl 1): 69–72, 1983

    Google Scholar 

  2. Fisher B, Redmond CK, Wickerham DL, Rockette HE, Brown A, and other NASBP investigators: Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy. Breast Cancer Res Treat 3: 355–364, 1983

    PubMed  Google Scholar 

  3. Rose C, Thorpe SM, Anderson KW, Pedersen BV, Mouridsen HT, Toft MD, Rasmussen BB: Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet: 16–19, 1985

  4. Clark GM, Osborne CK, McGuire WL: Correlations between estrogen receptor, progesterone receptor and patient characteristics in human breast cancer. J Clin Oncol 2: 1102–1109, 1984

    PubMed  Google Scholar 

  5. Smyth CM, Reeve TS: Two aids in oestrogen receptor characterisation. Aust NZ J Surg 52: 161–164, 1982

    Google Scholar 

  6. Smyth CM, Benn DE, Reeve TS: Comparison of an estrogen receptor related protein — the ERD5 antigen, with estrogen and progesterone receptors in breast cancer patients. Pathology 19, 1987 (in press)

  7. Leclerq G, Heuson JC: Therapeutic significance of sexsteroid hormone receptors in the treatment of breast cancer. Eur J Cancer 13: 1205–1215, 1977

    PubMed  Google Scholar 

  8. Block GE, Ellis RS, De Sombre E, Jensen E: Correlation of estrophilin content of primary mammary cancer to eventual endocrine treatment. Ann Surg 88: 372–376, 1978

    Google Scholar 

  9. McGuire WL: Steroid hormone receptors in breast cancer treatment strategy. Recent Prog Hormone Res 36: 135–156, 1980

    Google Scholar 

  10. Thorpe SM, Rose C, Pedersen BV, Rasmussen BR: Estrogen and progesterone receptor profile patterns in primary breast cancer. Breast Cancer Res Treat 3: 103–110, 1983

    PubMed  Google Scholar 

  11. Sarrif AM, Durant J: Evidence that estrogen-receptor-negative, progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptor. Cancer 48: 1215–1220, 1981

    PubMed  Google Scholar 

  12. Saez S, Martin PM, Chouvet CD: Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Cancer Res 38: 3468–3473, 1978

    PubMed  Google Scholar 

  13. McCarty KS Jr, Silva JS, Cox EB, Leight GS, Wells SA, McCarty KS Sr: Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast. Ann Surg 197: 123–127, 1983

    PubMed  Google Scholar 

  14. Leclerq G, Bojar H, Goussard J, Nicholson RI, Pichon M-F, Pifanelli A, Pousette A, Thorpe S, Lonsdorfer M: Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: A European multicenter study. Cancer Res (Suppl) 46: 42335–42362, 1986

    Google Scholar 

  15. Heise E, Gorlick M: Estradiol receptor in human breast cancers throughout the menstrual cycle. Oncology 39: 340–344, 1982

    PubMed  Google Scholar 

  16. Coradini D, Cappelletti V, Miodini P, Ronchi E, Scarone G, Di Fonzo G: Tumori 70: 339–344, 1984

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Sydney, Royal North Shore Hospital, 2065, St. Leonards, N.S.W., Australia

    Christine M. Smyth, Diana E. Benn & Thomas S. Reeve

Authors
  1. Christine M. Smyth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diana E. Benn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas S. Reeve
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smyth, C.M., Benn, D.E. & Reeve, T.S. Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies. Breast Cancer Res Tr 11, 45–50 (1988). https://doi.org/10.1007/BF01807557

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01807557

Key words

Search

Navigation